Drug Substance Manufacturing - Microbial Fermentation

Drug Substance Manufacturing - Microbial Fermentation
Product Description

12,000 L  commercial manufacturing capacity in multi-licensed facility  Two trains  each with 6,000 L of capacity which can be used with flexible scales
Large-scale GMP facilities licensed by EMA, FDA & MHLW for clinical and commercial global supplies 
Protein refolding, large-scale HPLC, explosion proof units, chemical modifications to prolong molecule half-life and purification-only for all kind of recombinant proteins from microbial technologies 
Several plasmid-based gene expression systems for E. coli, yeast and Pseudomonas 
Process and analytical development 
GMP batch release testing 
Manufacturing of Fab fragment, peptide hormones, plasmid DNA, scaffolds, recombinant proteins, enzymes and recombinant vaccines like VLPs

Read more Show less

Boehringer Ingelheim Biopharmaceuticals GmbH

  • DE
  • 2023
    On CPHI since
  • 5000+
    Employees
Company types
CMO/CDMO
View company profile
Categories
more categories Show less
Specifications
  • Details
    Offering clinical and commercial supplies from our facility in Vienna/Austria.

    Product Track Record: 20 microbial biopharmaceuticals brought to the market together with our partners. 
  • Supplied from
    Austria
More specifications Fewer specifications
Sales Markets
Show more Show less

Boehringer Ingelheim Biopharmaceuticals GmbH

  • DE
  • 2023
    On CPHI since
  • 5000+
    Employees
Company types
CMO/CDMO
View company profile

More Products from Boehringer Ingelheim Biopharmaceuticals GmbH (5)

  • Downstream Only - Processing for microbial derived proteins

    Product Downstream Only - Processing for microbial derived proteins

    Proven track record in ‘downstream- processing- only’ services Service description: - Intermediate materials, that need to be further purified and/or conjugated - Hormones or other recombinant proteins like virus like particles from inclusion bodies or from biomass - Peptides from inclusion bodies, biom...
  • Early development service for microbial fermentation

    Product Early development service for microbial fermentation

    High throughput process development services for E. coli and yeast based on high degree of automation and digitalization to speed up time to clinic for diverse protein formats e.g., scaffolds, enzymes, pDNA, sub-unit vaccines and antibody fragments. Service description: - Genetic engineering, cell line an...
  • Tech Transfer

    Product Tech Transfer

    Efficient tech transfers from customers or within own global bio-manufacturing network, launch preparation and commercial supply readiness for drug substance and drug product. Service description: - Long-standing track record in product launches - 47 biopharmaceuticals brought to the market - Tailored to...
  • Drug Substance Manufacturing - Mammalian Cell Cultures

    Product Drug Substance Manufacturing - Mammalian Cell Cultures

    • Around 430,000 L total commercial capacity for cell culture  • Manufacturing sites around the globe: Biberach/Germany, Vienna/Austria, Fremont, CA/USA and Shanghai/ China- from 2,000 up to 15,000 L bioreactors  • GMP facilities licensed by EMA, FDA, MHLW and other authorities ...
  • Aseptic Filling

    Product Aseptic Filling

    • Clinical and commercial capacities and technology for vials  • Formulations for liquids and lyophilizates vials (flexible vial sizes from 2 mL to 100 mL) • Flexible filling volumes for clinical and commercial supply  • Manual and automated visual inspections  • Globally licensed ...

Boehringer Ingelheim Biopharmaceuticals GmbH resources (2)